datetime,headline,summary,related,lang,source
2020-12-09 07:00:00-05:00,Zimmer Biomet and Hospital for Special Surgery (HSS) Partner to Advance Innovation on mymobility® with Apple Watch® Remote Care Management System,"WARSAW, Ind. and NEW YORK, Dec. 9, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, and Hospital for Special Surgery (HSS), the world's leading academic medical center focused on musculoskeletal health, today announced…",ZBH,en,PR Newswire
2020-12-09 03:13:06-05:00,"Orthopedic Splints and Casts Market Use of Technology In The Industry - Essity Aktiebolag - BSN Medical, DJO Global, Inc., Zimmer Biomet Holdings, Inc., Ossur Americas, Inc., Prime Medical, Inc., DeRoyal Industries, Inc.","Global orthopedic Splints and Casts Market, by Product Type (Casts and Splints), by End User (Hospitals, Orthopedic Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 2,160.6 million in 2018",ZBH,en,OpenPR
2020-12-07 06:30:01-05:00,"Powered Surgical Instruments Market by Top Key Players, Size, Subdivision & Market Dynamics Forces | Stryker Corporation, Conmed Corporation, Zimmer Biomet Holdings, Inc.",Powered surgical instruments are surgical devices that are used to perform various tasks in a surgical procedure and are operated through a power source. Powered surgical instruments are technologically advanced devices that assist surgeons in carrying out surgical procedures in,ZBH,en,OpenPR
2020-11-28 00:00:00-05:00,Fidelma Cook: I once had a house in France ... now I have a souped-up Zimmer,It backs against the wall,ZBH,en,Herald Scotland
2020-11-26 06:27:19-05:00,"Latest Advancement in Tooth Replacement Market: Updates And Incisive Outlook To 2027 | Institut Straumann AG, Dentsply Sirona, Zimmer Biomet Holdings, Danaher","Dental implants are an option when patients need to replace a single tooth, or when patients are missing several teeth in different areas of your mouth. Top Companies Covered in this Report: 1. Institut Straumann AG 2. Dentsply Sirona Inc. 3. Zimmer Biomet","ZBH,XRAY",en,OpenPR
2020-11-23 02:37:44-05:00,"Joint Pain Injection Market With Top Key Players like Sanofi-aventis U.S. LLC, a Sanofi Company, Pnika Therapeutics, Chugai Pharmaceutical Co., Ltd, Ferring B.V, Biovefizer, Antus Fidia Pharma USA, Zimmer Biomet Holdings, Flexion Therapeutics, Seikagaku C",Joint pain injections are medicinal fluids inserted in the body of patients to get faster relief from severe pain. The joint pain injections are used to reduce inflammation in the joints. There are several types of injections available in the,ZBH,en,OpenPR
2020-11-21 06:55:58-05:00,"Cranio Maxillofacial Fixation Devices Market Insights and Global Outlook During 2020 to 2026; Zimmer Biomet Holdings, Inc. (NYSE:ZBH), Stryker Corp.(NYSE:SYK), DePuy Synthes, Medtronic PLC(NYSE:MDT)","MarketInsightsReport has published a report titled Global Cranio Maxillofacial Fixation Devices Market research report 2020 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players.",ZBH,en,OpenPR
2020-11-19 01:59:06-05:00,"Unexpected Growth Seen in Cranio Maxillofacial Implant Market 2020-2025 | Global Key Vendors - J&J, Zimmer, Medtronic, B Braun, Boston Medical, Stryker, Medartis","The report covers a forecast and an analysis of the Cranio Maxillofacial Implant Market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2025 based on",ZBH,en,OpenPR
2020-11-19 00:20:46-05:00,"Surgical Equipment Market With Top Leading Players like Alcon Laboratories, Aspen Surgical Products, B. Braun Melsungen AG, Becton, Dickinson and Company, Ethicon, Medtronic, Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Holdings","An off-the-shelf report on Surgical Equipment Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as",ZBH,en,OpenPR
2020-11-17 07:00:00-05:00,Zimmer Biomet to Present at 2020 Evercore ISI HealthCONx Conference and Piper Sandler 32nd Annual Virtual Healthcare Conference,"WARSAW, Ind., Nov. 17, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal care, today announced that President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at the 2020 Evercore ISI…",ZBH,en,PR Newswire
2020-11-16 22:20:00-05:00,This Is What Hedge Funds Bought And Sold In Q3: Complete 13F Summary,"This Is What Hedge Funds Bought And Sold In Q3: Complete 13F Summary Tyler Durden Mon, 11/16/2020 - 22:20 While we live in a time when the holdings of the top 20 Robinhood ""investors"" have far more information value for markets and other traders than a glimpse into what hedge funds are doing, not in the least because retail investors are outperforming both the S&P500 and hedge funds 10-to-1… ... unfortunately there is still no regulatory requirement for even superstar retail investors to disclose their holdings, which is why we have to be satisfied with the quarterly 13-F publication spectacle, which just concluded today, and which revealed that even as tech stocks suffered two correction shakeouts since early September, hedge funds mostly stuck with the ""safety"" of tech stocks during the third quarter heading into the election, even as some hedge funds trimmed Amazon.com as the dominant e-commerce platform thrived amid a pandemic-fueled surge in online shopping, while others sold Netflix Courtesy of Bloomberg, below is a snapshot of what some of the most prominent tech stock additions as disclosed by today's barrage of 13F filings: Coatue Management doubled its holdings of Tesla in the three months ended Sept. 30, making the electric-vehicle maker its second-biggest publicly disclosed holding.","ZM,YUM,ZBH",en,Zero Hedge
2020-11-15 13:00:33-05:00,"Lyft's Zimmer talks future of workplace, electric vehicles","Lyft scored a major victory when California voters passed Proposition 22, allowing app-based companies to treat drivers as contractors instead of employees and saving the company from what many anticipated would be crippling expenses",ZBH,en,ABC News
2020-11-11 11:39:09-05:00,"Orthobiologics Market with (Covid-19) Impact Analysis: Top Industry Trends & Segments Forecast 2020-2027 | Stryker Corporation, Zimmer Biomet Holdings, Wright Medical Group, Arthrex","Increase in demand for advanced treatment and surge in geriatric population across the globe are anticipated to significantly drive the growth of the orthobiologics market. Furthermore, rise in prevalence of spinal injuries, osteoarthritis, soft tissue injuries, and upsurge in awareness",ZBH,en,OpenPR
2020-11-11 09:17:58-05:00,"Lyft Co-Founder Discusses Last-Mile Delivery, Taking On Uber Eats","Lyft Inc (NASDAQ: LYFT ) Co-Founder and President John Zimmer joined Andrew Sorkin on CNBC’s “Squawk Box” Wednesday morning to discuss the company’s third-quarter earnings. Zimmer on Earnings: Lyft reported third-quarter revenue of $499.7 million, which beat the Street consensus target of $486.5 million. Revenue declined 48% year-over-year in the third quarter, but rose 47% from the second quarter. “We had a great quarter,” said Zimmer. The co-founder of the ride-sharing company said the “recovery is happening.” Zimmer … Full story available on Benzinga.com",ZBH,en,Benzinga
2020-11-09 10:57:44-05:00,"Orthopedic Implants Market Increasing Industry Share Impact of Forecast Report 2020-2025 | Zimmer Biomet, DePuy Synthes, Stryker, Smith & Nephew, Medtronic, NuVasive, Globus, Acumed, MicroPort","The exclusive research report on Global Orthopedic Implants market 2020 categorizes the market based on market overview, regions, analysis by types and applications, market dynamics, manufacturers profiles and forecast 2020-2025. Global Orthopedic Implants Market overview: An orthopedic implant is a medical device",ZBH,en,OpenPR
2020-11-05 18:00:00-05:00,Zimmer Biomet Announces Preliminary Results from mymobility® Clinical Study at 2020 AAHKS Annual Meeting,"WARSAW, Ind., Nov. 5, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced preliminary results from a prospective, randomized controlled clinical trial to evaluate the impact of mymobility® with Apple…",ZBH,en,PR Newswire
2020-11-05 08:19:00-05:00,"Worldwide Sports Medicine Device Industry to 2025 - Players Include Arthrex, Stryker & Zimmer Biomet Among Others - ResearchAndMarkets.com","DUBLIN--(BUSINESS WIRE)--The ""Sports Medicine Device Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Product Type"" report has been added to ResearchAndMarkets.com's offering. This report is a professional and in-depth study on the current state of the global Sports Medicine Device market with a focus on the Chinese market. The report provides key statistics on market of Sports Medicine Device. It is a valuable source of guida",ZBH,en,Business Wire
2020-11-04 12:51:03-05:00,"Healthcare Education Solutions Market New Study Reveals to Boost Growth | Leading Players - Siemens Healthcare, Zimmer Biomet, Stryker, Medtronic, Johnson & Johnson","A market research analysis and estimations carried out in this Healthcare Education Solutions Market report aids businesses in gaining knowledge about what is already there in the market, what market looks forward to, the competitive background & steps to be",ZBH,en,OpenPR
2020-11-02 07:00:00-05:00,Zimmer Biomet to Present at Stifel Virtual Healthcare Conference,"WARSAW, Ind., Nov. 2, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal care, today announced that President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at the Stifel Virtual Healthcare…",ZBH,en,PR Newswire
2020-10-29 06:00:00-05:00,Zimmer Biomet to Present at the SVB Leerink CybeRx Series Conference,"WARSAW, Ind., Oct. 29, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal care, today announced that Vice President and General Manager of Worldwide Robotics Liane Teplitsky will be presenting at the SVB Leerink CybeRx Series: Devices…",ZBH,en,PR Newswire
2020-10-26 09:06:54-05:00,"Lumbar Disc Herniation Treatment Market Is Projected To Gain Significant Value By 2020 - 2027 | Stryker Corporation, Medtronic, Zimmer Biomet Holdings, Globus Medical",Lumbar disc herniation treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence,ZBH,en,OpenPR
2020-10-26 01:55:25-05:00,"Global Healthcare Education Solutions Market Analysis 2020 With COVID 19 Impact Analysis| Leading Players In-depth Analysis Research Report Foresight to 2027 || GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Zimmer","Healthcare education solutions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and",ZBH,en,OpenPR
2020-10-25 09:37:00-05:00,"Trending Report on Regenerative Medicines Market 2020-2027| Stryker Corporation, Zimmer Biomet Holdings, Medtronic, Baxter International","To provide the global outlook of the Regenerative Medicines Market a new statistical study has added by HealthCare Intelligence Markets to its massive database. During the analysis of this market the existing industries, as well as upcoming start-ups, have been",ZBH,en,OpenPR
2020-10-24 12:39:44-05:00,"Brokerages Expect Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to Announce $1.05 Earnings Per Share","Wall Street analysts expect Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to post earnings of $1.05 per share for the current fiscal quarter, Zacks reports. Eleven analysts have provided estimates for Zimmer Biomet’s earnings. The highest EPS estimate is $1.22 and the lowest is $0.72. Zimmer Biomet posted earnings per share of $1.77 in the same quarter […]",ZBH,en,The Olympia Report
2020-10-24 07:50:44-05:00,"Zacks: Brokerages Anticipate Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Will Post Quarterly Sales of $1.71 Billion","Brokerages expect Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to announce $1.71 billion in sales for the current quarter, Zacks Investment Research reports. Eleven analysts have issued estimates for Zimmer Biomet’s earnings, with estimates ranging from $1.67 billion to $1.76 billion. Zimmer Biomet posted sales of $1.89 billion during the same quarter last year, which would indicate […]",ZBH,en,The Olympia Report
2020-10-22 23:30:58-05:00,Northland Securities Begins Coverage on Zimmer Biomet (NYSE:ZBH),"Northland Securities assumed coverage on shares of Zimmer Biomet (NYSE:ZBH) in a research report report published on Tuesday morning, AR Network reports. The brokerage issued a market perform rating and a $150.00 target price on the medical equipment provider’s stock. A number of other research firms have also recently commented on ZBH. SVB Leerink lifted […]",ZBH,en,Stock Observer
2020-10-21 04:37:33-05:00,"Orthobiologics Market Expected to Reach $6,870 Million by 2025| With Major Key Companies Stryker Corporation, Zimmer Biomet Holdings, Wright Medical Group, Medline Industries","According to a new report published by Allied Market Research, titled,""Orthobiologics Market by Product, Application, Type, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,""the market was valued at $4,870 million in 2017, and is projected to",ZBH,en,OpenPR
2020-10-09 08:32:44-05:00,"Cervical Total Disc Replacement Device Market Is Projected To Attain Substantial Absolute $ Opportunity In Terms Of Value Through 2026 | Stryker Corporation, Medtronic Plc, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., FH Orthopedics, Orthofix Medic","""Cervical Total Disc Replacement Device Market″ Report evaluated the historical and current performance of the market, especially highlighting the key trends and growth opportunities. Cervical Total Disc Replacement Device market report discussed this scenario of market size with reference to",ZBH,en,OpenPR
2020-10-07 07:06:16-05:00,"Healthcare Education Solutions Market 2020 Major Players Hitting the Reset Button, Koninklijke Philips N.V., Siemens Healthcare, Zimmer Biomet, Stryker, Medtronic, Johnson & Johnson","To prepare this Healthcare Education Solutions Market research report, an array of objectives of market research has been considered. While formulating this market report, marketing administration stays extremely aware about certain things that include the minds of target markets, feelings,",ZBH,en,OpenPR
2020-10-05 09:04:28-05:00,"Cervical Total Disc Replacement Device Market Expected To Boost The Global Industry Growth By 2026 | Stryker Corporation, Medtronic Plc, Zimmer Biomet Holdings, Inc., Globus Medical, Inc., FH Orthopedics","""Cervical Total Disc Replacement Device Market″ Report evaluated the historical and current performance of the market, especially highlighting the key trends and growth opportunities. Cervical Total Disc Replacement Device market report discussed this scenario of market size with reference to",ZBH,en,OpenPR
2020-10-05 03:56:26-05:00,"Orthopedic Soft Tissue Repair Market Analysis, Size, Growth rate, Industry Challenges and Opportunities to 2026 | Stryker, Arthrex, Zimmer Biomet, DePuy Synthes, etc.",Global Orthopedic Soft Tissue Repair Market The investigative study on the Global Orthopedic Soft Tissue Repair Market by Reports and Data offers insightful information about the market size and current and emerging trends and elements influencing the growth of the,ZBH,en,OpenPR
2020-10-01 01:17:47-05:00,"Global Leigh Syndrome Treatment Market 2020: Growth, Emerging Trends And Forecast By GlaxoSmithKline Plc, Brother Enterprises, Huazhong, Zhejiang Tianxin, Stryker Corporation, Zimmer Biomet Holdings, Inc","A new research study from “Data Bridge Market Research” with title Leigh Syndrome Treatment Insights 2020GlaxoSmithKline Plc, Brother Enterprises, Huazhong, Zhejiang Tianxin, Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Technology, Inc., Integra LifeSciences Holdings Corporation among other domestic",ZBH,en,OpenPR
2020-09-29 03:06:24-05:00,"Minimally Invasive Spinal Implant Market Global Opportunity Analysis and Industry Forecast 2020-2027 | Medtronic, DePuy Synthes, Zimmer Biomet, Stryker, NuVasive","Global Minimally Invasive Spinal Implant Market has been brewing up and influencing the international economy with respect to revenue, growth rate, sale, market share, and size. The Global Minimally Invasive Spinal Implant Market research report provides a rational explanation to",ZBH,en,OpenPR
2020-09-10 15:30:00-05:00,Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2020,"WARSAW, Ind., Sept. 10, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2020….",ZBH,en,PR Newswire
2020-09-08 06:00:00-05:00,Zimmer Biomet to Present at Morgan Stanley Virtual Global Healthcare Conference,"WARSAW, Ind., Sept. 8, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at the Morgan Stanley…",ZBH,en,PR Newswire
2020-09-03 06:00:00-05:00,Zimmer Biomet to Present at Wells Fargo 2020 Virtual Healthcare Conference,"WARSAW, Ind., Sept. 3, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at the Wells Fargo 2020…",ZBH,en,PR Newswire
2020-08-13 12:55:06-05:00,"'Fast Money Halftime Report' Picks For August 13: Ollie;s, Zimmer Biomet And More","On CNBC's ""Fast Money Halftime Report,"" Jenny Harrington suggested that Zimmer Biomet Holdings Inc (NYSE: ZBH ) is a buy. She said it has a high … Full story available on Benzinga.com",ZBH,en,Benzinga
2020-08-04 13:33:56-05:00,"The rise and fall of Men's Wearhouse, the menswear chain that promised customers for five decades 'You're going to like the way you look — I guarantee it'","Tailored Brands — the parent company of Men's Wearhouse, Jos. A. Bank, Moores, and K&G Fashion Superstore — filed for Chapter 11 bankruptcy protection on Monday, citing the impact of the coronavirus on the decline of suits and formal wear. However, back when the world was still dressing up and going out, Men's Wearhouse has been a go-to destination to help Americans suit up for nearly 50 years. Founded in 1973 by George Zimmer, the company rose to prominence in part thanks to its well-known commercials starring the founder himself delivering his trademark line: ""You're going to like the way you look: I guarantee it."" We took a look at the rise and fall of Men's Wearhouse over the decades. Visit Business Insider's homepage for more stories . For nearly 50 years, Men's Wearhouse was synonymous with its tailored bargain suits and television commercials promising its customers: ""You're going to like the way you look — I guarantee it."" However, with most of the country still homebound amid the coronavirus outbreak, suits and formalwear have gone by the wayside and left the fate of Men's Wearhouse in the balance.",ZBH,en,Business Insider
2020-08-02 10:08:50-05:00,"The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings","Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in, with big pharma tie-ups flaunting positive tidings. In the biggest ever coronavirus funding deal, the Sanofi SA (NASDAQ: SNY ) GlaxoSmithKline plc (NYSE: GSK ) won a joint $2.1 billion U.S. federal funding award. Here're the key catalysts for the unfolding week: Conferences 72nd National Hemophilia Foundation's Annual Bleeding Disorders Meeting 2020 (virtual meeting): Aug. 1-8 PDUFA Dates FDA is scheduled to rule on DBV TECHNOLOGIE/S' ADR (NASDAQ: DBVT ) Viaskin peanut allergy patch Wednesday. However, cancellation of the Adcom meeting scheduled May 15 has poured cold water on the prospects of an approval coming through. Trevena Inc (NASDAQ: TRVN ) has a tryst with the FDA Friday, with respect to the NDA for its pain drug oleceridine, which was once rejected by the agency on the premise of inadequacy of clinical data.",ZBH,en,Benzinga
2020-07-15 14:02:52-05:00,Why Zimmer Biomet's Stock Is Trading Higher Today,"Zimmer Biomet Holdings Inc (NASDAQ: ZBH ) shares are trading higher on Wednesday after SVB Leerink maintained a Buy rating on the stock and raised its price target from $136 to $146. Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer … Full story available on Benzinga.com",ZBH,en,Benzinga Feeds
2020-06-10 10:30:50-05:00,Zimmer (ZBH) Up 18.1% Since Last Earnings Report: Can It Continue?,Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,ZBH,en,Zacks Investment Research
2020-05-11 06:45:15-05:00,Zimmer Biomet (ZBH) Beats Q1 Earnings Estimates,"Zimmer (ZBH) delivered earnings and revenue surprises of 22.30% and -0.34%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?",ZBH,en,Zacks Investment Research
2020-04-30 06:00:00-05:00,Zimmer Biomet Holdings to Present at the Bank of America Merrill Lynch 2020 Health Care Conference,"WARSAW, Ind., April 30, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that President and CEO Bryan Hanson and Executive Vice President and Chief Financial Officer Suky Upadhyay will be participating in…",ZBH,en,PR Newswire
2020-04-20 11:56:58-05:00,The Sound Of Electric Vehicles,"Have you felt the power of ""Time"" when watching Inception? Did you feel the immense power of ""Now We Are Free"" when watching Gladiator? What about the music from Pirates of the Caribbean, the Batman Trilogy, and The Da Vinci Code? All of that music was composed by the legendary German composer Hans Zimmer. In addition to his film work, Zimmer has also signed on to produce a series of mini-soundtracks to feature in BMW's (OTC: BMWYY ) all-electric 2021 BMW i4. The BMW i4 is anticipated to be the first genuine rival to Tesla Motor Inc's (NASDAQ: TSLA ) Model 3. Moreover, Hans Zimmer's soundtracks will be setting the tone, and we mean literally, as they will be the sound of all future electric BMWs. In an industry where differentiation is the … Full story available on Benzinga.com",ZBH,en,Benzinga Feeds
2020-04-16 06:00:00-05:00,Zimmer Biomet Announces Change to Virtual-only Format for 2020 Annual Meeting of Shareholders,"WARSAW, Ind., April 16, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced a change in the location of its 2020 Annual Meeting of Shareholders (the ""2020 Annual Meeting""). In the interest of the health and safety of our shareholders, team members and…",ZBH,en,PR Newswire
2020-04-13 07:14:00-05:00,"Morningstar pinpoints 32 undervalued stocks to buy right now, featuring their analysts' best ideas in each sector","Morningstar analysts recently compiled a list of more than two-dozen stocks across each S&P 500 sector that they believe are trading below their true value. They listed two or three of their ""best ideas"" for each sector. Google parent Alphabet, energy giant Schlumberger, and healthcare company Pfizer were among those included. More broadly, Morningstar thiink the wider S&P 500 is undervalued after one of its worst first quarters ever. Visit BI Prime for more investing stories . For Morningstar, the recent stock market rout has yielded big buying opportunities for investors in every sector. ""We think stocks overall are undervalued,"" the research firm wrote in a recent note clients, pointing to the brutal first quarter showing for the vast majority of major indexes worldwide. With the S&P 500 turning in a 20% first-quarter decline and continuing to swing wildly in the second quarter, analysts have identified undervalued names, or stocks they believe are trading below their true value. ""Of the roughly 800 North American stocks we cover, a hefty 67% have an undervalued rating of 4 or 5 stars, whereas three months ago, only about 20% were undervalued,"" Jeffrey Stafford, Morningstar's director of North American equity research, said in a recent report.",ZBH,en,Business Insider
2020-04-06 15:55:39-05:00,BRIEF-Zimmer Biomet Holdings Says Withdrawing Full-Year Financial Guidance It Previously Issued On February 4,Zimmer Biomet Holdings Inc:,ZBH,en,Reuters
2020-04-06 06:01:00-05:00,Zimmer Biomet Holdings Is Only Temporarily Out of Joint,"Focus on coronavirus patients has hospitals deferring elective surgeries, but eventually patients who need knee, hip and other replacements will be back on surgical schedules….ZBH",ZBH,en,TheStreet
2020-03-18 08:12:00-05:00,Here's Why You Should Add Zimmer Biomet to Your Portfolio Now,Investors continue to be optimistic about Zimmer Biomet (ZBH) on its strong segmental and international results in the fourth quarter of 2019.,ZBH,en,Zacks Investment Research
2020-03-12 09:15:00-05:00,"Zimmer Biomet Grows on Strong Emerging Market, Innovation",Zimmer Biomet (ZBH) solidifies its foothold in the emerging markets on strong operational and sales performance.,ZBH,en,Zacks Investment Research
2020-03-05 11:31:00-05:00,Why Is Zimmer (ZBH) Down 12.5% Since Last Earnings Report?,Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,ZBH,en,Zacks Investment Research
2020-02-28 09:36:00-05:00,Zimmer Biomet Holdings to Present at Raymond James & Associates' 41st Annual Institutional Investors Conference,"WARSAW, Ind., Feb. 28, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in Raymond James & Associates' 41st Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando. Suky…",ZBH,en,PR Newswire
2020-02-20 07:06:25-05:00,"The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Arcus Biosciences Inc (NYSE: RCUS ) Ascendis Pharma A/S (NASDAQ: ASND ) AVITA MED LTD/S ADR (NASDAQ: RCEL )(reacted to its half-yearly results) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) Calithera Biosciences Inc (NASDAQ: CALA ) ChemoCentryx Inc (NASDAQ: CCXI ) Cue Biopharma Inc (NASDAQ: CUE )(said its therapeutic Immuno-STAT platform will be featured in a Merck & Co., Inc.'s (NYSE: MRK ) presentation at the Antigen Specific Immune Tolerance Drug Development Summit) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GENMAB A/S/S ADR (NASDAQ: GMAB )(reacted to its quarterly and full-year results) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Insulet Corporation (NASDAQ: PODD ) Intuitive Surgical, Inc.",ZBH,en,Benzinga
2020-02-14 08:23:03-05:00,"The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering","The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL ) AtriCure Inc. (NASDAQ: ATRC ) Beam Therapeutics Inc (NASDAQ: BEAM ) BioXcel Therapeutics Inc (NASDAQ: BTAI ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) ChemoCentryx Inc (NASDAQ: CCXI ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fortress Biotech (NASDAQ: FBIO ) Insulet Corporation (NASDAQ: PODD ) Krystal Biotech Inc (NASDAQ: KRYS ) Masimo Corporation (NASDAQ: MASI ) NeoGenomics, Inc. (NASDAQ: NEO ) Nevro Corp (NYSE: NVRO ) Recro Pharma Inc (NASDAQ: REPH ) ResMed Inc. (NYSE: RMD ) Revolution Medicines Inc (NASDAQ: RVMD ) (went public Thursday) Syneos Health Inc (NASDAQ: SYNH ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) Taro Pharmaceutical Industries Ltd. (NYSE: TARO ) West Pharmaceutical Services Inc.","ZTS,ZBH,ZLAB",en,Benzinga Feeds
2020-02-10 03:28:00-05:00,Here's Why You Should Add Zimmer (ZBH) to Your Portfolio,Investors continue to be optimistic about Zimmer's (ZBH) potential on its strong segmental and international results for the fiscal fourth quarter.,ZBH,en,Zacks Investment Research
2020-02-07 07:32:45-05:00,"The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (NASDAQ: ALEC ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Arvinas Inc (NASDAQ: ARVN ) Ascendis Pharma A/S (NASDAQ: ASND ) Beam Therapeutics Inc (NASDAQ: BEAM ) (IPOed Thursday) ChemoCentryx Inc (NASDAQ: CCXI ) Eli Lilly And Co (NYSE: LLY ) Fulgent Genetics Inc (NASDAQ: FLGT ) Insmed Incorporated (NASDAQ: INSM ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ ) Novartis AG (NYSE: NVS ) PPD Inc (NASDAQ: PPD ) (IPOed Thursday) Principia Biopharma Inc (NASDAQ: PRNB ) Profound Medical Corp (NASDAQ: PROF ) PTC Therapeutics, Inc (NASDAQ: PTCT ) ResMed Inc. (NYSE: RMD ) Revance Therapeutics Inc (NASDAQ: RVNC ) (announced FDA acceptance of BLA for DAXI to treat frown lines) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb.","ZBH,ZSAN",en,Benzinga
2020-02-05 07:43:12-05:00,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 4) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (NASDAQ: ALEC ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Applied Therapeutics Inc (NASDAQ: APLT ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT )(IPOed Jan. 31) Black Diamond Therapeutics Inc (NASDAQ: BDTX )(IPOed Jan. 30) ChemoCentryx Inc (NASDAQ: CCXI ) Eli Lilly And Co (NYSE: LLY ) Fate Therapeutics Inc (NASDAQ: FATE ) Frequency Therapeutics Inc (NASDAQ: FREQ ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Hologic, Inc. (NASDAQ: HOLX ) Insmed Incorporated (NASDAQ: INSM )(reacted to positive analyst actions following a positive data readout reported Monday) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Molecular Templates Inc (NASDAQ: MTEM ) Neoleukin Therapeutics Inc (NASDAQ: NLTX ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Quest Diagnostics Inc (NYSE: DGX ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc.",ZBH,en,Benzinga
2020-02-04 14:44:04-05:00,Zimmer Biomet : Description Non-GAAP Financial Guidance | MarketScreener,"ZIMMER BIOMET HOLDINGS, INC. Non-GAAP Financial Guidance For the Year Ending December 31, 2020 … | February 4, 2020",ZBH,en,MarketScreener
2020-02-04 08:03:53-05:00,Zimmer Biomet beats Q4 consensus,"Zimmer Biomet (ZBH) Q4 results: Revenues: $2,125.7M (+2.6%); Knees: $760.6M (+4.3%); Hips: $511.3M (+2.7%); S.E.T.: $473.7M (+2.8%); Spine & CMF: $197.3M (",ZBH,en,Seeking Alpha
2020-02-04 06:59:11-05:00,Zimmer Biomet : Description Reconciliation of Effective Tax Rate to Adjusted Effective Tax Rate | MarketScreener,"ZIMMER BIOMET HOLDINGS, INC. Reconciliation of Effective Tax Rate to Adjusted Effective Tax Rate For the Quarterly and Year-to-Date Periods… | February 4, 2020",ZBH,en,MarketScreener
2020-02-04 06:03:09-05:00,"Zimmer Biomet EPS beats by $0.03, beats on revenue",Zimmer Biomet (NYSE:ZBH): Q4 Non-GAAP EPS of $2.30 beats by $0.03; GAAP EPS of $1.54 misses by $0.13. Revenue of $2.13B (+2.9% Y/Y) beats by $20M. Press Re,ZBH,en,Seeking Alpha
2020-02-04 06:00:00-05:00,Zimmer Biomet Announces Fourth Quarter and Full-Year 2019 Financial Results,"WARSAW, Ind., Feb. 4, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter and year ended December 31, 2019. The Company reported fourth quarter net sales of $2.126 billion, an increase of 2.6% over the prior year period,…",ZBH,en,PR Newswire
2020-01-30 09:26:49-05:00,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 29) 10X Genomics Inc (NASDAQ: TXG ) Agile Therapeutics Inc (NASDAQ: AGRX ) Aptose Biosciences Inc (NASDAQ: APTO ) Catalent Inc (NYSE: CTLT ) Cabaletta Bio Inc (NASDAQ: CABA )(announced grant of orphan drug designation for its DSG3-CAART for the treatment of pemphigus vulgaris) AtriCure Inc. (NASDAQ: ATRC ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Fate Therapeutics Inc (NASDAQ: FATE ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ )(confirmed it is working on treatment/vaccines for coronavirus) Nevro Corp (NYSE: NVRO ) Profound Medical Corp (NASDAQ: PROF ) Quest Diagnostics Inc (NYSE: DGX ) ResMed Inc. (NYSE: RMD ) Satsuma Pharmaceuticals Inc (NASDAQ: STSA )(reacted to publication of positive data readout for its lead drug candidate) Tandem Diabetes Care Inc (NASDAQ: TNDM ) West Pharmaceutical Services Inc. (NYSE: WST ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Jan. 29) Avanos Medical Inc (NYSE: AVNS ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc. (NASDAQ: ELGX ) Galectin Therapeutics Inc.",ZBH,en,Benzinga
2020-01-29 02:36:00-05:00,What's in the Cards for Zimmer Biomet (ZBH) in Q4 Earnings?,Gains from developments in business segments are likely to get reflected in Zimmer Biomet's (ZBH) revenue results for the fourth quarter and 2019.,ZBH,en,Zacks Investment Research
2020-01-28 12:31:25-05:00,Zimmer Biomet (ZBH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,ZBH,en,Zacks Investment Research
2020-01-23 09:01:00-05:00,Zimmer (ZBH) Stock Hits New 52-Week High: What's Driving It?,Zimmer (ZBH) is optimistic about maintaining its growth momentum on several recent developments.,ZBH,en,Zacks Investment Research
2020-01-22 04:05:00-05:00,Zimmer Biomet Rides on Product Launches Despite Pricing Woes,"Zimmer Biomet's (ZBH) execution of its priority agenda including quality remediation, supply recovery efforts and product introductions looks impressive.",ZBH,en,Zacks Investment Research
2020-01-08 08:30:00-05:00,Zimmer Biomet Appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer,"WARSAW, Ind., Jan. 8, 2020 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Keri P. Mattox has been appointed to the newly created position of Senior Vice President, Investor Relations and Chief…",ZBH,en,PR Newswire
2020-01-06 02:53:00-05:00,Here's Why You Should Hold on to Zimmer (ZBH) Stock for Now,Investors continue to be optimistic about Zimmer (ZBH) on its stellar segmental performance in Q3.,ZBH,en,Zacks Investment Research
2019-12-24 03:28:00-05:00,Zimmer Biomet Hits New 52-Week High: What's Driving It?,Zimmer Biomet (ZBH) is optimistic about maintaining growth momentum on several recent positive developments.,ZBH,en,Zacks Investment Research
2019-12-19 11:30:00-05:00,Zimmer Biomet Focuses on Priority Areas Despite Pricing Woes,"Zimmer Biomet (ZBH) is executing well within its priority areas like quality remediation, supply recovery efforts and product rollouts.",ZBH,en,Zacks Investment Research
2019-12-19 07:00:00-05:00,Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of Fourth Quarter 2019 Results,"WARSAW, Ind., Dec. 19, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter sales and earnings conference call will be broadcast over the Internet on Tuesday, February 4, 2020, at 8:30 a.m. Eastern Time. A news release detailing the…",ZBH,en,PR Newswire
2019-12-16 07:00:00-05:00,Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2019,"WARSAW, Ind., Dec. 16, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the fourth quarter of 2019….",ZBH,en,PR Newswire
2019-12-05 11:31:17-05:00,Zimmer (ZBH) Up 3.6% Since Last Earnings Report: Can It Continue?,Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,ZBH,en,Zacks Investment Research
2019-12-05 07:14:16-05:00,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Dec. 4) Allakos Inc (NASDAQ: ALLK )(announced exploration of strategic options, including a potential sale) Allergan plc (NYSE: AGN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Applied Therapeutics Inc (NASDAQ: APLT ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Bausch Health Companies Inc (NYSE: BHC ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Flexion Therapeutics Inc (NASDAQ: FLXN ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Gossamer Bio Inc (NASDAQ: GOSS ) Incyte Corporation (NASDAQ: INCY ) Inspire Medical Systems Inc (NYSE: INSP ) IVERIC bio Inc (NASDAQ: ISEE ) Jounce Therapeutics Inc (NASDAQ: JNCE ) Kodiak Sciences Inc (NASDAQ: KOD ) Krystal Biotech Inc (NASDAQ: KRYS ) Merck & Co.","ZBH,ZLAB",en,Benzinga
2019-11-19 10:43:00-05:00,Zimmer (ZBH) Hits 52-Week High: What's Driving the Stock?,Zimmer (ZBH) is optimistic about maintaining its growth momentum on several recent positive developments.,ZBH,en,Zacks Investment Research
2019-11-19 07:56:14-05:00,"The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 18) 10X Genomics Inc (NASDAQ: TXG )(IPOed Sept. 12) 89bio Inc (NASDAQ: ETNB ) (IPOed Nov. 11) Antares Pharma Inc (NASDAQ: ATRS ) Arvinas Inc (NASDAQ: ARVN ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Cabaletta Bio Inc (NASDAQ: CABA ) Crispr Therapeutics AG (NASDAQ: CRSP ) DexCom, Inc. (NASDAQ: DXCM Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) )(announced a partnership with Novo Nordisk A/S (NYSE: NVO ) for developing RNAi therapies) Frequency Therapeutics Inc (NASDAQ: FREQ )(reacted to its third-quarter results) GENMAB A/S/S ADR (NASDAQ: GMAB ) IGM Biosciences Inc (NASDAQ: IGMS ) Insulet Corporation (NASDAQ: PODD ) Karuna Therapeutics Inc (NASDAQ: KRTX )( announced positive results for its mid-stage schizophrenia drug) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Kodiak Sciences Inc (NASDAQ: KOD ) Krystal Biotech Inc (NASDAQ: KRYS ) The Medicines Company (NASDAQ: MDCO )(announced full results of its ORION-9 Phase 3 study of inclisiran at the American Heart Association 2019 annual meeting) Medtronic PLC (NYSE: MDT ) Neurocrine Biosciences, Inc.","ZBH,ZEAL",en,Benzinga
2019-11-18 04:49:29-05:00,"Insider Selling: Zimmer Biomet Holdings Inc (NYSE:ZBH) Insider Sells 15,171 Shares of Stock","Zimmer Biomet Holdings Inc (NYSE:ZBH) insider Aure Bruneau sold 15,171 shares of the firm’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $146.78, for a total value of $2,226,799.38. Shares of Zimmer Biomet stock opened at $146.78 on Monday. The firm has a market cap of […]",ZBH,en,Modern Readers
2019-11-13 07:10:18-05:00,"The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 12) ACADIA Pharmaceuticals Inc (NASDAQ: ACAD ) Allergan plc (NYSE: AGN ) Amgen, Inc. (NASDAQ: AMGN ) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Celgene Corporation (NASDAQ: CELG ) Crispr Therapeutics AG (NASDAQ: CRSP ) Diplomat Pharmacy Inc (NYSE: DPLO )( warned of going concern risk) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) DexCom, Inc. (NASDAQ: DXCM ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Galera Therapeutics Inc (NASDAQ: GRTX ) Insulet Corporation (NASDAQ: PODD ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) XOMA Corp (NASDAQ: XOMA ) Zai Lab Ltd (NASDAQ: ZLAB ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov.","ZBH,ZLAB",en,Benzinga
2019-11-08 07:38:42-05:00,FY2019 Earnings Estimate for Zimmer Biomet Holdings Inc Issued By Jefferies Financial Group (NYSE:ZBH),"Zimmer Biomet Holdings Inc (NYSE:ZBH) – Equities research analysts at Jefferies Financial Group reduced their FY2019 earnings per share (EPS) estimates for Zimmer Biomet in a report issued on Tuesday, November 5th. Jefferies Financial Group analyst R. Denhoy now forecasts that the medical equipment provider will post earnings per share of $7.84 for the year, […]",ZBH,en,Modern Readers
2019-11-08 07:00:00-05:00,Zimmer Biomet Holdings to Present at the 2nd Annual Evercore ISI HealthCONx Conference,"WARSAW, Ind., Nov. 8, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the Evercore ISI HealthCONx Conference at the Four Seasons Hotel in Boston. Suky Upadhyay, Executive Vice President and Chief…",ZBH,en,PR Newswire
2019-11-05 06:30:48-05:00,"Zimmer Biomet : Contributors to Geography Sales Change For the Three Months Ended September 30, 2019 and 2018 | MarketScreener","Zimmer Biomet Holdings, Inc. Contributors to Geography Sales Change For the Three Months Ended September 30, 2019 and 2018 … | November 5, 2019",ZBH,en,MarketScreener
2019-11-05 06:30:27-05:00,"Zimmer Biomet : Contributors to Product Category Sales Change For the Three Months Ended September 30, 2019 and 2018 | MarketScreener","Zimmer Biomet Holdings, Inc. Contributors to Product Category Sales Change For the Three Months Ended September 30, 2019 and 2018 … | November 5, 2019",ZBH,en,MarketScreener
2019-11-05 06:10:22-05:00,Zimmer Biomet : Description Reconciliation of Gross Profit & Margin to Adjusted Gross Profit & Margin | MarketScreener,"ZIMMER BIOMET HOLDINGS, INC. Reconciliation of Gross Profit & Margin to Adjusted Gross Profit & Margin For the Quarterly and… | November 5, 2019",ZBH,en,MarketScreener
2019-11-05 06:10:21-05:00,Zimmer Biomet : Description Reconciliation of Cash Flow from Operating Activities to Free Cash Flow | MarketScreener,"ZIMMER BIOMET HOLDINGS, INC. Reconciliation of Cash Flow from Operating Activities to Free Cash Flow For the Quarterly and Year-to-Date… | November 5, 2019",ZBH,en,MarketScreener
2019-11-05 06:00:00-05:00,Zimmer Biomet Announces Third Quarter 2019 Financial Results,"WARSAW, Ind., Nov. 5, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended September 30, 2019. The Company reported third quarter net sales of $1.892 billion, an increase of 3.0% over the prior year period, and an…",ZBH,en,PR Newswire
2019-10-29 09:33:04-05:00,Zimmer Biomet (ZBH) Reports Next Week: Wall Street Expects Earnings Growth,Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,ZBH,en,Zacks Investment Research
2019-09-27 07:20:00-05:00,Here's Why You Should Hold Zimmer Biomet (ZBH) Stock for Now,"Investor confidence continues to be high in Zimmer Biomet (ZBH), thanks to solid prospects.",ZBH,en,Zacks Investment Research
2019-09-18 12:26:45-05:00,"Canaccord Upgrades Zimmer Biomet On Incremental Opportunities In 2020, Beyond","Zimmer Biomet Holdings Inc (NYSE: ZBH ) seems to be on the verge of beginning a multiyear cycle of accelerating top-line growth, according to Canaccord Genuity. The Analyst Canaccord Genuity’s Kyle Rose upgraded Zimmer Biomet from Hold to Buy, while raising the price target from $137 to $167. The Thesis The strategic and cultural changes that Zimmer Biomet had been implementing over the past 18 months now seem to have taken hold, Rose said in the upgrade note. He added that this was evident in the encouraging second quarter results and management’s upbeat commentary. Rose mentioned that Zimmer Biomet’s turnaround plan was focused … Full story available on Benzinga.com",ZBH,en,Benzinga
2019-09-18 08:22:00-05:00,Zimmer Biomet's New JuggerStitch to Grow Sports Medicine Line,"Zimmer Biomet's (ZBH) JuggerStitch claims to offer a less invasive, all-suture, knotless approach to meniscal repair procedures.",ZBH,en,Zacks Investment Research
2019-09-13 06:40:02-05:00,"The Daily Biotech Pulse: All Eyes On Aimmune, Ritter Stumbles In Late-Stage Study, Catalyst Shelves Offering Plans","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 11) Ardelyx Inc (NASDAQ: ARDX ) Avedro Inc (NASDAQ: AVDR ) Celgene Corporation (NASDAQ: CELG ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) The Medicines Company (NASDAQ: MDCO ) Medtronic PLC (NYSE: MDT ) Nevro Corp (NYSE: NVRO ) Radius Health Inc (NASDAQ: RDUS ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Down In The Dumps (Biotech stocks hitting 52-week lows on Sept. 11) CELYAD SA/ADR (NASDAQ: CYAD ) Endologix, Inc. (NASDAQ: ELGX ) Myovant Sciences Ltd (NYSE: MYOV ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Karuna Therapeutics Inc (NASDAQ: KRTX ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Titan Pharmaceuticals, Inc. common stock (NASDAQ: TTNP )(filed for a $12 million secondary offering) Tocagen Inc (NASDAQ: TOCA )( reported that its late-stage brain cancer study did not meet the primary endpoint) Trinity Biotech plc (NASDAQ: TRIB ) Stocks In Focus Ardelyx Gets FDA Nod For Constipation Drug Ardelyx announced the FDA has approved its tenapanor, brand name Ibsrela, a 50mg twice-daily oral pill for the treatment of irritable bowel syndrome with constipation in adults.","ZBH,ZEAL",en,Benzinga
2019-09-10 02:00:00-05:00,Zimmer Biomet (ZBH) Launches Persona Revision for Knee Care,"Zimmer Biomet (ZBH) prepares for the commercial launch of improvised knee replacement procedures through its flagship program, Persona Revision Knee System.",ZBH,en,Zacks Investment Research
2019-09-02 02:07:00-05:00,"Zimmer Biomet Succeeds in Priority Areas, Suffers Pricing Woe","With regard to product suite, Zimmer Biomet (ZBH) steadily wins an array of key regulatory clearances for knee, brain and spine applications under its ROSA platform over the past several months.",ZBH,en,Zacks Investment Research
2019-08-25 08:30:22-05:00,Why Is Zimmer (ZBH) Up 7.9% Since Last Earnings Report?,Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,ZBH,en,Zacks Investment Research
2019-08-22 10:40:00-05:00,Zimmer Biomet Wins Nod for Spinal Teather to Treat Scoliosis,"Zimmer Biomet's (ZBH) AVBT solution, The Tether, uses a solid, flexible cord in place of traditional metal rods to pull on the outside of a scoliosis curve.",ZBH,en,Zacks Investment Research
2019-07-31 06:06:00-05:00,"The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 30) Acasti Pharma Inc (NASDAQ: ACST ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Medpace Holdings Inc (NASDAQ: MEDP )(reported strong second-quarter results ) Novocure Ltd (NASDAQ: NVCR ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 30) Alimera Sciences Inc (NASDAQ: ALIM )(reacted to second-quarter results) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Aquestive Therapeutics Inc (NASDAQ: AQST ) Champions Oncology Inc (NASDAQ: CSBR ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Equillium Inc (NASDAQ: EQ ) Medtronic PLC (NYSE: MDT ) Obseva SA (NASDAQ: OBSV ) Rhythm Pharmaceuticals Inc (NASDAQ: RYTM ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) Trevi Therapeutics Inc (NASDAQ: TRVI ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Stocks In Focus Roche Extends Offer Period For Spark Buy Once Again Roche Holdings AG Basel ADR (OTC: RHHBY ) and Spark Therapeutics Inc (NASDAQ: ONCE ) announced Wednesday Roche has extended the offering period for its previously announced tender offer to buy all outstanding shares of Spark for $114.50 …","ZBH,ZIOP",en,Benzinga
2019-07-27 05:55:29-05:00,Zimmer Biomet Holdings (ZBH) Q2 2019 Earnings Call Transcript -- The Motley Fool,"ZBH earnings call for the period ending June 30, 2019.",ZBH,en,The Motley Fool
2019-07-26 10:54:00-05:00,"Zimmer Biomet (ZBH) Beats on Q2 Earnings, Narrows '19 View",Zimmer Biomet (ZBH) observes strength in the Asia Pacific and EMEA regions as well as in the S.E.T. business.,ZBH,en,Zacks Investment Research
2019-07-26 06:30:04-05:00,Zimmer Biomet (ZBH) Q2 Earnings and Revenues Beat Estimates,"Zimmer (ZBH) delivered earnings and revenue surprises of 0.52% and 0.34%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",ZBH,en,Zacks Investment Research
2019-07-23 09:12:00-05:00,Can New Product Menu Aid Zimmer Biomet's (ZBH) Q2 Earnings?,"With consecutive product approvals, Zimmer Biomet (ZBH) becomes the first company on the global frontier with 510(k) clearance for Brain, Spine and Knee offerings on a single robotic platform.",ZBH,en,Zacks Investment Research
2019-07-19 09:30:37-05:00,Zimmer Biomet (ZBH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?,Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,ZBH,en,Zacks Investment Research
2019-06-13 11:42:00-05:00,Zimmer Biomet Grows Internationally Despite Pricing Pressure,Zimmer Biomet (ZBH) witnesses strength in the EMEA and APAC regions as well as in the Spine & CMF business.,ZBH,en,Zacks Investment Research
2019-05-26 08:30:28-05:00,Why Is Zimmer (ZBH) Down 8.2% Since Last Earnings Report?,Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,ZBH,en,Zacks Investment Research
2019-04-26 18:20:13-05:00,Zimmer Biomet Holdings (ZBH) Q1 2019 Earnings Call Transcript,"ZBH earnings call for the period ending March 31, 2019.",ZBH,en,The Motley Fool
2019-04-26 14:00:00-05:00,Zimmer Biomet Holdings Sales and Earnings Slip in Q1,"The musculoskeletal healthcare company continues to try to turn things around, with limited success in the first quarter.",ZBH,en,The Motley Fool
2019-04-26 12:46:25-05:00,"Zimmer Biomet Holdings, Inc. (ZBH) CEO Bryan Hanson on Q1 2019 Results - Earnings Call Transcript","Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q1 2019 Results Earnings Conference Call April 26, 2019, 08:30 AM ET Company Participants Coleman Lannum - Senior Vice P",ZBH,en,Seeking Alpha
2019-04-25 16:30:19-05:00,Zimmer Biomet Q1 2019 Earnings Preview,"Zimmer Biomet (NYSE:ZBH) is scheduled to announce Q1 earnings results on Friday, April 26th, before market open. The consensus EPS Estimate is $1.86 (-2.6%",ZBH,en,Seeking Alpha
2019-04-25 05:38:00-05:00,Will Pricing Pressure Hurt Zimmer Biomet (ZBH) Q1 Earnings?,"With Zimmer Biomet (ZBH) focusing solely on this restructuring initiative, chances are slim for the company to post promising growth performances across its operating segments.",ZBH,en,Zacks Investment Research
2019-04-24 06:36:07-05:00,Needham likes Zimmer Biomet in premarket analyst action,No summary available.,ZBH,en,Seeking Alpha
2019-04-18 21:30:00-05:00,Earnings Preview: Zimmer Biomet (ZBH) Q1 Earnings Expected To Decline,https://www.investing.com/analysis/earnings-preview-zimmer-biomet-zbh-q1-earnings-expected-to-decline-200408764,ZBH,en,Investing.com
2019-03-26 09:17:00-05:00,Zimmer Biomet's FDA 510(k) Nod Widens Robotic Offerings,"With the FDA nod, Zimmer Biomet (ZBH) attains the status of being the first company to boast the 510(k) clearance for Brain, Spine and Knee offerings on a single robotic platform globally.",ZBH,en,Zacks Investment Research
2019-03-22 14:46:03-05:00,Zimmer Biomet Holdings: Management Expects Modest Growth,No summary available.,ZBH,en,Seeking Alpha
2019-03-18 03:04:00-05:00,Zimmer Biomet Solid on Global Prospects Despite Price Pressure,"Zimmer Biomet (ZBH) has been working to strengthen foothold in emerging markets. However, the company has been facing continued pricing pressure.",ZBH,en,Zacks Investment Research
2019-03-05 22:48:08-05:00,Daily Insider Ratings Round Up 3/4/19,No summary available.,ZBH,en,Seeking Alpha
2019-02-26 16:40:03-05:00,Zimmer Biomet files for mixed shelf offering,No summary available.,ZBH,en,Seeking Alpha
2019-02-22 08:50:00-05:00,Exploring 3 Medical And Safety Device Manufacturers,No summary available.,ZBH,en,Seeking Alpha
2019-02-16 15:56:50-05:00,Daily Insider Ratings Round Up 2/14/19,No summary available.,ZBH,en,Seeking Alpha
2019-02-15 12:59:10-05:00,FDA issues draft guidance on non-binding feedback on inspections,No summary available.,ZBH,en,Seeking Alpha
2019-02-13 10:49:03-05:00,Daily Insider Ratings Roundup 2/11/19,No summary available.,ZBH,en,Seeking Alpha
2019-02-12 11:22:08-05:00,"Medical devices maintain strength, IHI up 11% ytd",No summary available.,ZBH,en,Seeking Alpha
2019-02-11 17:17:51-05:00,Daily Insider Ratings Round Up 2/8/19,No summary available.,ZBH,en,Seeking Alpha
2019-02-11 05:49:00-05:00,Insider Weekends: Chairman Of Kinder Morgan Steps Up Insider Purchases,No summary available.,"ZBH,ZS",en,Seeking Alpha
2019-02-08 11:47:52-05:00,"Daily Insider Ratings Round Up - Feb. 6, 2019",No summary available.,ZBH,en,Seeking Alpha
2019-02-01 13:38:06-05:00,Zimmer Biomet Holdings Inc (ZBH) CEO Bryan Hanson on Q4 2018 Results - Earnings Call Transcript,No summary available.,ZBH,en,Seeking Alpha
2019-02-01 06:04:24-05:00,"Zimmer Biomet beats by $0.01, beats on revenue",No summary available.,ZBH,en,Seeking Alpha
2019-01-31 17:30:51-05:00,Zimmer Biomet Q4 Earnings Preview,No summary available.,ZBH,en,Seeking Alpha
2019-01-30 13:03:40-05:00,Stereotaxis: A Leader In Robotic Heart Surgery Is Ripe To Be Acquired,No summary available.,ZBH,en,Seeking Alpha
